This week’s Australian pharmacy news highlights growing conversations around medication safety, responsible prescribing, and the long-term consequences of medicine use. From increased scrutiny of telehealth-issued weight-loss prescriptions to renewed concerns about antibiotic overuse and updated guidance for off-label prescribing, these developments reinforce the profession’s critical role in safeguarding patient outcomes and supporting evidence-based care.
Pharmacists Warned Over Telehealth Weight-Loss Prescriptions
Pharmacists are being urged to carefully assess weight-loss medication prescriptions issued through telehealth services, particularly as demand for these treatments continues to grow. Concerns have been raised that some prescriptions may lack sufficient clinical oversight or patient assessment. The warning reinforces the importance of professional judgment and ensuring medicines are supplied safely and appropriately. As telehealth expands, pharmacists remain a key safeguard in patient care.
👉 Learn more about the concerns raised.
Antibiotic Use Reaches Concerning Levels
Health experts are warning that antibiotic use remains higher than desirable, increasing the risk of antimicrobial resistance. Rising resistance can make common infections more difficult to treat and reduce the effectiveness of life-saving medicines. Stakeholders are calling for stronger stewardship measures, including appropriate prescribing and better public awareness. The issue continues to be a significant global and local public health challenge.
🔍 Explore the latest concerns around antibiotic use.
Updated Guidance for Off-Label Medicine Use
New guidance has been released to help healthcare professionals navigate the complexities of prescribing and dispensing medicines for off-label use. The updated recommendations aim to improve consistency in decision-making while ensuring patients are adequately informed about treatment options. Clear documentation, clinical justification, and effective communication remain central themes of the guidance. The update supports safer and more transparent patient care practices.
